PubRank

Agnès Chompret

Author PubWeight™ 38.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007 13.90
2 Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008 3.41
3 Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002 2.70
4 Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 2006 2.25
5 Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol 2003 1.36
6 Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. J Natl Cancer Inst 2004 1.25
7 Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 2004 1.18
8 Patients' characteristics and rate of Internet use to obtain cancer information. J Public Health (Oxf) 2006 1.08
9 Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene. Oncogene 2003 1.07
10 Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations. J Med Genet 2009 1.06
11 Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees. Cancer Epidemiol Biomarkers Prev 2005 1.03
12 BRAF as a melanoma susceptibility candidate gene? Cancer Res 2003 1.00
13 Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institut Gustave-Roussy in France. Pediatr Blood Cancer 2004 0.97
14 Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing. Eur J Cancer 2006 0.97
15 Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene. Int J Cancer 2005 0.91
16 New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment. Genes Chromosomes Cancer 2007 0.88
17 Sex ratio among the offspring of BRCA mutation carriers. JAMA 2004 0.86
18 Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 2005 0.86
19 BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma. Fam Cancer 2007 0.84
20 Genetic and environmental factors in cutaneous malignant melanoma. Biochimie 2002 0.84
21 Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients. Hum Mutat 2009 0.82
22 BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations. Cancer Epidemiol Biomarkers Prev 2003 0.79
23 A 22-year French experience with solid tumors in children with Down syndrome. Pediatr Hematol Oncol 2003 0.76
24 Role of radiation dose in the risk of secondary leukemia after a solid tumor in childhood treated between 1980 and 1999. Int J Radiat Oncol Biol Phys 2010 0.75